Lv11
40 积分 2023-10-31 加入
Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety
10小时前
已完结
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
10小时前
已完结
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial
10小时前
已完结
A Concise Review on Tyrosine Kinase Targeted Cancer Therapy
4天前
已完结
A Concise Review on Tyrosine Kinase Targeted Cancer Therapy
9天前
已完结
Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism
16天前
已完结
Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
23天前
已完结
Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseases
1个月前
已完结
Activating JAK3 Mutations in Transient Myeloproliferative Disorder and Acute Megakaryoblastic Leukemia Accompanying Down Syndrome
1个月前
已关闭
Activating JAK3 Mutations in Transient Myeloproliferative Disorder and Acute Megakaryoblastic Leukemia Accompanying Down Syndrome
1个月前
已关闭
皖公网安备34019202002308
